Innovate Biopharmaceuticals Inc Stock Nasdaq
Equities
US61174L5012
Investment Holding Companies
Sales 2021 | - | Sales 2022 | - | Capitalization | 16.32M 22.34M |
---|---|---|---|---|---|
Net income 2021 | -36M -49.26M | Net income 2022 | -43M -58.84M | EV / Sales 2021 | - |
Net cash position 2021 | 46.83M 64.08M | Net Debt 2022 | 7.08M 9.69M | EV / Sales 2022 | - |
P/E ratio 2021 |
-6.47
x | P/E ratio 2022 |
-0.37
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.29% |
1st Jan change | Capi. | |
---|---|---|
+173.89% | 6.55B | |
+2.29% | 983M | |
+5.57% | 1.05B | |
+41.91% | 872M | |
+20.36% | 786M | |
+1.72% | 664M | |
-.--% | 600M | |
-2.15% | 593M | |
+40.25% | 639M |